Low-Grade Urothelial Carcinoma:

Similar documents
Diagnostic Challenge. Department of Pathology,

Cytopathology Case Presentation #8

Carcinosarcoma of the Ovary

Cytology : first alert of mesothelioma? Professor B. Weynand, UCL Yvoir, Belgium

Breast Fine Needle Aspiration Cytology Reporting : A Study of Application of Probabilistic Approach

Case Report of Renal Cell Carcinoma Diagnosed in Voided Urine Confirmed by CD10 Immunocytochemistry

Information Model Requirements of Post-Coordinated SNOMED CT Expressions for Structured Pathology Reports

330 Diagnostic Cytopathology, Vol 34, No 5 # 2006 WILEY-LISS, INC.

INFLAMMATION AND REACTIVE CHANGES IN CERVICAL EPITHELIUM

ORIGINAL ARTICLES. Materials and Methods

Validation of BRAF Mutational Analysis in Thyroid Fine Needle Aspirations: A Morphologic- Molecular Approach

Explanation of your PAP smear

Intraobserver and Interobserver Reproducibility of WHO and Gleason Histologic Grading Systems in Prostatic Adenocarcinomas

Basic Professional Training Program for Associate Medical Technologist

The Diagnosis of Cancer in the Pathology Laboratory

Your bladder cancer diary. WA Cancer and Palliative Care Network

The Role of Genetic Testing in the Evaluation of Thyroid Nodules. Thyroid Cancer and FNA. Thyroid Cancer. Pure Follicular Cancers.

DESMOPLASTIC SMALL ROUND CELL TUMOR: A RARE PATHOLOGY PUZZLE

Gladwyn Leiman, MCCCh, FIAC, FRCPath Scott Anderson, MD

Renal Cell Carcinoma: Advances in Diagnosis B. Iványi, MD

ATLAS OF HEAD AND NECK PATHOLOGY THYROID PAPILLARY CARCINOMA

EIN. (Endometrial Intraepithelial Neoplasia): Improved Criteria for diagnosing endometrial precancer. Stanley J. Robboy, MD, FCAP,

OBJECTIVES By the end of this segment, the community participant will be able to:

ALTHOUGH excellent accounts have been published in recent years of

Chapter 2 Indication, Collection, and Laboratory Processing of Cytologic Samples

Nicole Kounalakis, MD

Saturation Biopsy vs. 3D Spatial Biopsy vs. Free Hand Ultrasound biopsy for Targeted Prostate Cancer Therapies

KIDNEY CARCINOMA ASSOCIATED WITH XP11.2 TRANSLOCATION / TFE3 (ASPL-TFE3) GENE FUSION

MEDICAL POLICY SUBJECT: MOLECULAR MARKERS IN FINE NEEDLE ASPIRATES OF THE THYROID EFFECTIVE DATE: 11/19/15

Histopathology of Major Salivary Gland Neoplasms

Interobserver Reproducibility of Gleason Grading of Prostatic Carcinoma: Urologic Pathologists

20 Diagnostic Cytopathology, Vol 36, No 1 ' 2007 WILEY-LISS, INC.

Corporate Medical Policy Molecular Markers in Fine Needle Aspirates of the Thyroid

Something Old, Something New.

General Rules SEER Summary Stage Objectives. What is Staging? 5/8/2014

Outline. Workup for metastatic breast cancer. Metastatic breast cancer

Polyps. Hyperplasias. CAP 2011: Course AP104. The High Risk Benign Endometrium. Mutter and Nucci 1

Thyroid Fine-Needle Aspiration Indications and Technique. Subcommittee members Zubair W. Baloch, MD, PhD Martha Bishop Pitman, MD

Pleural and Pericardial fluids a one year analysis

1. What is the prostate-specific antigen (PSA) test?

YOUR LUNG CANCER PATHOLOGY REPORT

EDUCATIONAL COMMENTARY - GRANULOCYTE FORMATION AND CHRONIC MYELOCYTIC LEUKEMIA

Frozen Section Diagnosis

Provider Reimbursement for Women's Cancer Screening Program

Liquid-based cytology

Nilesh P. Patel, MD, 1 Cullen A. Taylor, MD, 1* Edward A. Levine, MD, 2 Jacqueline K. Trupiano, MD, 1* and Kim R. Geisinger, MD 1.

Conflict of Interest. Overdiagnosis. Beyond Bethesda: Challenges with Indeterminate Thyroid Aspirates 4/17/2015. Jeffrey F.

Cytology of Lymph Nodes

BRAF in the diagnostic evaluation of thyroid nodules

The Use of Immunohistochemistry to Distinguish Reactive Mesothelial Cells From Malignant Mesothelioma in Cytologic Effusions

Pap smears, cytology and CCHC lab work and follow up

INTRODUCTION: CASE REPORT:

THE CYTOLOGY LABORATORY

Practical Effusion Cytology

Classificazioni citologiche: verso uno schema internazionale unificato?

Management of Abnormal PAP Smears. K Chacko, MD, FACP 2010 GIM Conference

Update on Mesothelioma

Cytodiagnosis of renal cell carcinoma A case report

chapter 5. Quality control at the population-based cancer registry

MAJOR PARADIGM SHIFT IN EARLY 1990S IN UNDERSTANDING RENAL CANCER

How To Test For Cancer

Molecular Diagnostics in Thyroid Cancer

Disclosures. Learning Objectives. Effusion = Confusion. Diagnosis Of Serous Cavity Effusions - Beware The Mesothelial Cell!

Squamous cell carcinoma located in the renal caliceal system: A case report and review of the literature

CT and MRI features of the Pathologic Subtypes of Papillary Renal Cell Carcinoma. Melissa Price, MD Aoife Kilcoyne, MD Mukesh G.

Histologic Subtypes of Renal Cell Carcinoma

Breast Imaging Made Brief and Simple. Jane Clayton MD Associate Professor Department of Radiology LSUHSC New Orleans, LA

SEMESTER VI 3 RD YEAR PATHOLOGY KIDNEY TUMORS

Malignant Mesothelioma in Body Fluids - with Special Reference to Differential Diagnosis from Metastatic Adenocarcinoma -

Cytology of Effusion Fluids. Cytology of Effusion Fluids. Types of Effusion Fluids. Anatomy. Causes of Effusions. Sampling of Effusion Fluids

Immunohistochemistry on cytology specimens from pleural and peritoneal fluid

Medullary Renal Cell Carcinoma Case Report

PATHOLOGY OF THE PLEURA: Mesothelioma and mimickers Necessity of Immunohistochemistry. M. Praet

CONTENTS: WHAT S IN THIS BOOKLET

Bone Marrow Evaluation for Lymphoma. Faizi Ali, MD Hematopathology Fellow William Beaumont Hospital

PRIMARY SEROUS CARCINOMA OF PERITONEUM: A CASE REPORT

Testing for HPV as an Objective Measure for Quality Assurance in Gynecologic Cytology

Hodgkin Lymphoma Disease Specific Biology and Treatment Options. John Kuruvilla

EDUCATIONAL COMMENTARY RED BLOOD CELLS AND WHITE BLOOD CELLS IN URINALYSIS

Writing Group for the AACE Thyroid Scientific Committee. Bernet V, Hupart KH, Parangi S and Woeber KA

Hematology Morphology Critique

Renal Tumors with Eosinophilic Cytoplasm: 2013 Classification. Jesse K. McKenney, MD Associate Head, Surgical Pathology

Infrared Thermography Not a Useful Breast Cancer Screening Tool

Disease/Illness GUIDE TO ASBESTOS LUNG CANCER. What Is Asbestos Lung Cancer? Telephone

Effusion cytology. Dr Alpha Tsui Royal Melbourne Hospital 2008

Early Prostate Cancer: Questions and Answers. Key Points

NATIONAL GUIDELINE FOR CERVICAL CANCER SCREENING PROGRAMME

Breast cancer close to the nipple: Does this carry a higher risk ofaxillary node metastasesupon diagnosis?

Evaluation and Management of the Breast Mass. Gary Dunnington,, M.D. Department of Surgery Internal Medicine Ambulatory Conference December 4, 2003

The evolving pathology of solitary fibrous tumours. Luciane Dreher Irion MREH / CMFT / NSOPS

Malignant Lymphomas and Plasma Cell Myeloma

Creation Date: 12/24/2008. Effective Date: 07/14/2009 Date of Revision/Review: 07/14/2009 Version #:1 Date of Next Review: 07/14/2010

why? 75 percent The percentage of healthy individuals over age 40 who will become critically ill at some time in the future. 3

Title: Immunohistochemical staining of radixin and moesin in prostatic adenocarcinoma

Lung Carcinomas New 2015 WHO Classification. Spasenija Savic Pathology

Prepublication Requirements

Cervical Cancer The Importance of Cervical Screening and Vaccination

Changes in Breast Cancer Reports After Second Opinion. Dr. Vicente Marco Department of Pathology Hospital Quiron Barcelona. Spain

Cystic Neoplasms of the Pancreas: A multidisciplinary approach to the prevention and early detection of invasive pancreatic cancer.

Atypical uterine leiomyoma: a case report and review of the literature

Transcription:

Low-Grade Urothelial Carcinoma: Reappraisal of the Cytologic Criteria on ThinPrep Wei Xin, M.D., Ph.D. 1 Stephen S. Raab, M.D. 2 and Claire W. Michael, M.D. 1 * The diagnostic criteria for low-grade urothelial lesions that have been described in the past were based on urinary specimens prepared by the cytospin method. Recognizing the recent popularity of the ThinPrep methodology and the cytologic alterations it introduces to the cellular features, we sought to evaluate the reproducibility of these criteria in ThinPrep urinary samples. One hundred twenty-six ThinPrep urinary specimens with a tissue diagnosis of low-grade urothelial carcinoma (LGUC) and 45 negative controls were evaluated. Three pathologists blindly reviewed the slides separately and the consensus on each feature was used in the study. Logistic regression analysis was used to determine which criteria in combination were most predictive of low-grade urothelial carcinoma. All specimens were evaluated for the following 18 features: nucleus/cytoplasm ratio, irregular nuclear border, cytoplasm homogeneity, cell clusters, high cellularity, prominent nucleoli, granular nuclear chromatin, hyperchromasia, acute inflammation, vesicular chromatin, nuclear molding, nuclear eccentricity, elongated nuclei, necrosis, anisonucleosis, irregular bordered fragments, absent cytoplasmic collar, and peripheral palisading. High nucleus-to-cytoplasm ratio, irregular nuclear borders, and homogeneous cytoplasm (combination sensitivity of 59% and specificity of 100%) were the best predictive features for LGUC. Minor predictive criteria were eccentric nuclei and nuclear molding. ThinPrep provides well preserved, cleaner specimens without significantly altering the morphology. The three key criteria applied in cytospin specimens to diagnose LGUC were reproducible in ThinPrep specimens. Diagn. Cytopathol. 2003; 29:125 129. 2003 Wiley-Liss, Inc. Key Words: low-grade urothelial carcinoma; ThinPrep; urine; cytology Bladder cancers account for 12,600 deaths and more than 56,500 new cases per year, with a male-to-female ratio of 2.7:1. 1 More than 90% of the bladder cancers are urothelial carcinomas. The papillary carcinomas outnumber the flat 1 Department of Pathology, University of Michigan Medical Center, Ann Arbor, Michigan 2 University of Pittsburgh, Pittsburgh, Pennsylvania *Correspondence to: Claire W. Michael, M.D., Department of Pathology, University of Michigan Hospitals, 1500 E. Medical Center Dr., Ann Arbor, MI 48109. E-mail: clairemi@med.umich.edu Received 27 December 2002; Accepted 3 April 2003 DOI 10.1002/dc.10311 Published online in Wiley InterScience (www.interscience.wiley.com). ones. The papillary urothelial tumors usually present as low grade at early stage and involve multiple sites. Although they often recur, they can be easily managed by local excision. 2,3 According to the 1998 World Health Organization and International Society of Urological Pathologists classification, papillary urothelial neoplasms are classified as papilloma, urothelial carcinoma with low malignant potential, low-grade urothelial carcinoma, and high-grade urothelial carcinoma. 4 Diagnosing low-grade urothelial carcinoma (LGUC) on cytologic specimen is very difficult, because the tumor cells are well differentiated, they may exhibit only a slight degree of atypia, and they closely resemble normal urothelial cells. Separating them from reactive, regenerative and reparative changes is not always possible. Increased nuclear-to-cytoplasmic (N/C) ratio, irregular nuclear membrane, and cytoplasmic homogeneity were three key features reported by Raab et al. 5,6 for diagnosing LGUC in cytospin specimens. ThinPrep preparation (Cytyc, Boxborough, MA) was initially tested on nongynecologic specimens, as a monolayer preparation, and was then introduced as an alternative to the conventional preparation for cervical smear to remove obscuring elements and improve the diagnosis. 7,8 In recent years, many laboratories have implemented the ThinPrep method in preparing nongynecologic specimens. The ThinPrep method provides a clear background with the absence of blood, cell debris, and inflammatory cells. However, ThinPrep alters the cellular morphology when compared with conventional preparations. Some of the reported cytologic alterations of ThinPrep specimens that may affect the interpretation of LGUC include fragmented papillary clusters, more single cells with apparent discohesion, cells appearing smaller and spindly, enhanced nucleoli, increased cytoplasmic density, and less vesicular chromatin. 9,10 In the present study, we undertook to evaluate those previously described features in ThinPrep specimens and the most important cytologic features for diagnosing LGUC. 2003 WILEY-LISS, INC. Diagnostic Cytopathology, Vol 29, No 3 125

XIN ET AL. Table I. Original Cytologic Diagnosis in Biopsy-confirmed Low-Grade Urothelial Carcinomas and Benign Changes Total Positive c Negative d Positive c Negative d LGUC a Benign b Washing e 23 27 0 17 67 Voided 14 62 0 28 104 a Tissue biopsy confirmed low-grade urothelial carcinoma case numbers. b Tissue biopsy confirmed benign lesion case numbers. c Positive cases includes both positive and suspicious for urothelial carcinoma. d Negative cases include atypical cells present and negative for carcinoma. e All washing specimens including catheter-collected specimens. Materials and Methods Cases The cytology pathology files at the University of Michigan Medical Center were reviewed retrospectively for the years 1995 2001. The selected ThinPrep cases included 49 bladder washings and 76 void urine specimens with corresponding tissue diagnosis of LGUC within 6 mo. Patient ages ranged from 41 to 88 yr of age, with a mean of 56 yr. In addition, 17 bladder washings and 28 voided urine samples with corresponding tissue diagnosis of inflammation, reactive, or regenerative features within 6 mo were selected as the control group. Patient ages ranged in age from 40 to 85 yr, with a mean of 54 yr. Table I summarizes the original cytology diagnoses. Evaluation Three pathologists blindly reviewed each case separately and evaluated the selected previously described eighteen cytologic features. These features are increased N/C ratio, irregular nuclear border, cytoplasm homogeneity, cell clusters, high cellularity, prominent nucleoli, granular nuclear chromatin, hyperchromasia, acute inflammation, vesicular chromatin, nuclear molding, nuclear eccentricity, elongated nuclei, necrosis, anisonucleosis, fragments with irregular border, absent cytoplasmic collar (cytoplasmic rim between the nucleus and cytoplasmic membrane), and peripheral palisading. 5,6 Samples of the above features are illustrated in Figure C-1. The consensus on each feature in each case was consequently reached. For statistical evaluation, we used the 2 test or Fisher s exact test (if any observed frequency was 5) to obtain P-values. 11,12 Results In biopsy-confirmed LGUC cases, the original diagnosis in ThinPrep washings, based on the three key criteria (increased N/C ratio, irregular nuclear membrane, and cytoplasmic homogeneity), had a sensitivity of 46% and specificity of 100%. The diagnosis of the ThinPrep voided urine samples gave a sensitivity of 18.4% and specificity of 100% (Table II). The washings had a much better sensitivity than voided specimens, when these criteria were used. Twelve features were statistically significant (P 0.01) in frequency between LGUC and benign changes in both washings and voided urine samples. These twelve features are increased N/C ratio, cytoplasmic homogeneity, irregular nuclear borders, nuclear eccentricity, nuclear molding, anisonucleosis, hyperchromatic nuclear chromatin, elongated nucleus, absent cytoplasmic collar, granular nuclear chromatin, cell clusters, and necrosis (Table III). Overall, the rate of incidence of these twelve features (except for necrosis) was much higher in washings than voided samples. Increased N/C ratio, irregular nuclear border, cytoplasmic homogeneity, and presence of several cell clusters had their highest incidence in the LGUC. Necrosis was present only in carcinoma cases and was rather infrequent. Table IV summarizes the sensitivity, specificity, positive predictive value and negative predictive value of the statistically significant twelve features for the diagnosis of LGUC. The increased N/C ratio, cytoplasmic homogeneity, and irregular nuclear border had high sensitivities (67.5%, 65.1%, and 57.1%, respectively) and specificities (82.2%, 84.4%, and 91.1%, respectively) on ThinPrep specimens. The positive predictive values (PPVs), which were all higher than 90%, were much higher than the negative predictive values, which were all lower than 50%. Nuclear eccentricity, nuclear molding, and anisonucleosis were also good predictors, with sensitivity and specificity 61.9% and 82.2%, 41.3% and 93.3%, and 34.1% and 97.8%, respectively. High cellularity, open chromatin, acute inflammation, irregularly bordered fragments, prominent nucleoli, and peripheral palisading were not statistically significant (P 0.01) either in washings or voided urine samples (Table V). Discussion In urine cytology, high-grade urothelial carcinoma and carcinoma in situ usually do not represent a diagnostic challenge. The urine samples in such cases are characterized by abundant cellularity, isolated and loose clusters of tumor cells with pleomorphism and polymorphism, high N/C ratio, enlarged and eccentric nucleus, hyperchromatic and coarse chromatin, irregular nuclear membrane, and vacuolated cytoplasm. 13 However, in LGUC, many of the above features do not occur frequently. Histologically, LGUC are characterized by an overall orderly appearance, but with easily recognizable variation of architectural and/or cytologic features. Cytologic atypia usually is definite but minimal, including changes in nuclear size, shape, and chromatin pattern. Therefore, the differentiation between low-grade tumor and benign reactive or reparative change is very difficult on cytologic specimens. 4,5,14 Increased N/C, irregular nuclear membrane, and cytoplasmic homogeneity have been proposed for diagnosing LGUC and, in combination, 126 Diagnostic Cytopathology, Vol 29, No 3

LOW-GRADE UROTHELIAL CARCINOMA ON THINPREP Fig. 1. Selected cytologic features in the diagnosing low-grade urothelial carcinoma in ThinPrep specimens. A: Aniso, anisonucleosis; Ecc Nucl, eccentric nucleus; High N/C, high N/C ratio. B: Cyto homo, cytoplasmic homogeneity. C: Molding, nuclear molding. D: Elong Nucl, elongated nucleus. E: Hyper chrom, hyperchromasia; Cyto collar, absence of cytoplasmic collar; Gran chrom, granular chromatin. F, Irreg Nucl Membrane, irregular nuclear membrane (Papanicolaou stain, 1,000). Table II. Sensitivity, Specificity, Positive Predictive Value and Negative Predictive Value Sensitivity Specificity PPV NPV Washing 46.0 100 100 38.6 Voided 18.4 100 100 31.1 Combined 29.4 100 100 33.8 PPV, positive predictive value; NPV, negative predictive value. these three criteria had a 45% sensitivity and 98% specificity in conventional (cytospin) bladder washings. 5 Urine cytology is still one of the main approaches to follow-up evaluation of patients with urothelial carcinomas. 15,16 There are two major types of urinary cytologic specimen: bladder washings (including catheterization specimens) and voided urine specimens. Voided urines are easy to obtain, and they represent the entire urinary tract. However, they usually have a low cellularity and carry a high incidence of degeneration and contamination. In contrast, bladder washings have a higher sensitivity, being more cellular with better cell preservation and less contamination. However, their collection is inconvenient and uncomfortable to the patient, and also carries an increased risk of infection. 15,17 A previous study claimed that ThinPrep could achieve better cellular preservation, cleaner background and high cellularity in voided urine samples compared to conventional preparations. 18 In this study, we found that increased N/C ratio, irregular nuclear membrane, and cytoplasmic homogeneity were still three key criteria in diagnosing LGUC in ThinPrep samples. In combination, these three features had a sensitivity of 59% and a specificity of 100%. We noted a slight difference between our sensitivity in the second review and the original cytologic diagnosis, which is not statistically significant (59% vs 46%). This is probably due to the variation of different observers criteria on identifying these cytologic features. Because urine cytology is more important as a screening test, high sensitivity is desirable. If we used either two of the three key criteria, the diagnosis would have a much higher sensitivity of 79% and a decreased specificity of 91%. To overcome this obstacle, other important features such as eccentric nucleus, nuclear molding and anisonucleosis were introduced. If we used two of the three key features plus either one of these other important features as the diagnostic standard, the diagnosis would have a slightly decreased sensitivity of 77% and a markedly increased specificity of 97%. Diagnostic Cytopathology, Vol 29, No 3 127

XIN ET AL. Table III. Comparison of Cytologic Features Present in Low-Grade Urothelial Carcinoma and Benign Lesions Specimen LGUC Benign P N/C ratio Wash 86.0 29.6 0.01 Urine 55.3 10.7 0.01 Cytoplasmic homogeneity wash 86.0 23.5 0.01 Urine 51.3 10.7 0.01 Irregular nuclear border Wash 78.0 11.8 0.01 Urine 43.4 7.1 0.01 Nuclear eccentricity Wash 82.0 17.6 0.01 Urine 48.7 17.9 0.01 Nuclear molding Wash 62.0 11.8 0.01 Urine 27.6 3.6 0.01 Anisonucleosis Wash 58.0 5.9 0.01 Urine 18.4 0.0 0.01 Hyperchromasia Wash 40.0 0.0 0.01 Urine 27.6 3.6 0.01 Elongated nucleus Wash 46.0 4.2 0.01 Urine 17.1 0.0 0.01 Absence of cytoplasmic collar Wash 36.0 5.9 0.01 Urine 15.8 0.0 0.01 Granular chromatin Wash 72.0 53.0 0.01 Urine 39.5 14.3 0.01 Cell cluster Wash 86.0 53.0 0.01 Urine 42.1 32.1 0.01 Necrosis Wash 8.0 0.0 0.01 Urine 9.2 0.0 0.01 LGUC, low-grade urothelial carcinoma. Table IV. Sensitivity, Specificity, Positive Predictive Value, and Negative Predictive Value of Washing and Voided Urine Specimens Sensitivity Specificity PPV NPV N/C ratio 67.5 82.2 91.4 47.4 Cytoplasmic homogeneity 65.1 84.4 92.1 46.3 Irregular nuclear border 57.1 91.1 94.7 43.2 Nuclear eccentricity 61.9 82.2 90.7 43.5 Nuclear molding 41.3 93.3 94.5 36.2 Anisonucleosis 34.1 97.8 97.9 34.6 Hyperchromasia 32.5 97.8 97.6 34.1 Elongated nucleus 28.6 97.8 97.3 32.8 Absence of cytoplasmic collar 23.8 97.8 96.8 31.4 Granular chromatin 52.4 71.1 83.5 34.8 Cell cluster 59.5 60.0 80.6 34.6 Necrosis 8.7 100.0 100.0 28.1 PPV, positive predictive value; NPV, negative predictive value; N/C, nuclear-to-cytoplasmic (ratio). Table V. Comparison of Cytologic Features Present in Low-Grade Urothelial Carcinoma and Benign Lesions Although the three key cytologic features (increased N/C ratio, irregular nuclear membrane, and cytoplasmic homogeneity) had similar occurrences in ThinPrep samples, some cytologic alterations were noted in ThinPrep samples. In carcinoma cases, nuclear molding and anisonucleosis had much relative higher incidences in ThinPrep washing samples (62% and 58% vs 6% and 27%, respectively, in cytospin samples). In noncarcinoma cases, only 6% had open or vesicular nuclear chromatin compared with 22.0% in Thin- Prep samples. 5 Nevertheless, this study confirms that despite such minor alterations ThinPrep produced well-preserved samples with even distribution of cells and noticeable absence of most obscuring elements, such as blood, inflammation, and proteinaceous background. The diagnostic criteria derived from conventionally prepared samples in diagnosing LGUC would still be applicable in ThinPrep samples. In addition, as we showed in the study, although the incidences of diagnostic cytologic features were relatively low in the voided urine samples when compared with washing samples, they shared similar patterns. Therefore, the diagnostic criteria applicable to washings would also apply to voided urine samples. References Specimen LGUC Benign P High cellularity Wash 70.0 47.0 0.08 Urine 46.1 42.9 0.20 Open chromatin Wash 22.0 17.6 0.20 Urine 10.5 3.6 0.50 Acute inflammation Wash 22.0 47.0 0.35 Urine 46.1 46.4 0.30 Fragments irregular border Wash 2.0 0.0 0.05 Urine 3.9 0.0 0.55 Prominent nucleoli Wash 58.0 47.0 0.23 Urine 15.8 25.0 0.75 Peripheral palisading Wash 18.0 5.9 0.39 Urine 5.3 0.0 0.29 LGUC, low-grade urothelial carcinoma. 1. Cancer Facts and Figures 2002. Atlanta, GA: American Cancer Society; 2002. p 4. 2. Reuter VE, Melamed MR. The urothelial tract: renal pelvis, ureter, urinary bladder, and urethra. In: Sternberg SS, Antonioli DA, Carter D, Mills SE, Oberman HA, editors. Diagnostic surgical pathology. 3rd ed. Philadelphia: Lippincott/Williams & Wilkins; 1999. p 1869 1873. 3. Murphy WM, Beckwith JB, Farrow GM. Atlas of tumor pathology. Tumors of the kidney, bladder, and related urinary structures. 3rd series, fascicle 11. Washington, DC: Armed Forces Institute of Patholology; 1994. p 193 199. 4. Epstein J, Amin M, Reuter V, Mostofi FK. World Health Organization/ International Society of Urological Pathology consensus classification of urothelial (transitional) neoplasms of urinary bladder. Bladder Consensus Conference Committee. Am J Surg Pathol 2000;24:160 162. 5. Raab SS, Lenel JC, Cohen MB. Low grade transitional cell carcinoma of the bladder. Cancer 1994;74:1621 1626. 6. Raab SS, Slagel DD, Jensen CS, et al. Transitional cell carcinoma: cytologic criteria to improve diagnostic accuracy. Mod Pathol 1996; 9:225 232. 7. Awen C, Hathways S, Eddy W, Voskuil R, Janes C. Efficacy of ThinPrep preparation of cervical smears: a 1,000 case, investigatorsponsored study. Diagn Cytopathol 1994;11:33 36. 8. Fischler DF, Toddy SM. Nongynecologic cytology utilizing the Thin- Prep processor. Acta Cytol 1996:40;669 675. 9. Michael CW, Hunter B. Interpretation of fine-needle aspirates processed by the ThinPrep technique: cytologic artifacts and diagnostic pitfalls. Diagn Cytopathol 2000;23:6 13. 128 Diagnostic Cytopathology, Vol 29, No 3

LOW-GRADE UROTHELIAL CARCINOMA ON THINPREP 10. Leung CS, Chiu B, Bell V. Comparison of ThinPrep and conventional preparations: nongynecologic cytology evaluation. Diagn Cytopathol 1997;16:368-371. 11. Campbell MJ, Machin D. Medical statistics. West Sussex England: John Wiley & Sons; 1990. p 63 78. 12. Le CT, Boen JR. Health and numbers: basic biostatistical methods. New York: Wiley-Liss; 1994. p 199 205. 13. DeMay RM. The arts and science of cytopathology: exfoliative cytology. Chicago: ASCP Press; 1996. p 385 410. 14. Badalament RA, Gay H, Gibas ES, et al. Monitoring endoscopic treatment of superficial bladder carcinoma by postoperative urinary cytology. J Urol 1987;138:760 762. 15. Murphy WM. Urinary cytology in diagnostic pathology. Diagn Cytopathol 1985;1:173 175. 16. Kannan V, Bose S. Low grade transitional cell carcinoma and instrument artifact: a challenge in urinary cytology. Acta Cytol 1993;37: 899 902. 17. Badalament RA, Hermansen DK, Kimmel M, et al. The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma. Cancer 1987;60:1423 1427. 18. Luthra UK, Pranab D, George J, Abdulla, MA, et al. Comparison of ThinPrep and conventional preparations: urine cytology evaluation. Diagn Cytopathol 1997;21:364 366. Diagnostic Cytopathology, Vol 29, No 3 129